Cosmos Health partners with Libytec to commercialize DIABIT-IS X in Greece

Cosmos Health Inc

Cosmos Health Inc

COSM

0.00
  • Cosmos Health entered a five-year distribution and promotion partnership with Libytec to commercialize its DIABIT-IS X diabetes drug in Greece.
  • Cosmos will supply DIABIT-IS X (sitagliptin); Libytec will manage distribution, medical information, and promotion across physicians, pharmacies, and hospitals.
  • DIABIT-IS X is a generic alternative to Merck’s Januvia; Januvia and Janumet generated about $4.5 billion in global sales in 2022.
  • The product is expected to be accessible via Greece’s national health insurance system, supporting broader patient reach.
  • The agreement is expected to improve revenue and cash-flow visibility, supporting expansion into additional European markets over time.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cosmos Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607131300OMX_____CNEWS_EN_GNW9761225_en) on July 13, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.